Panacea Biotec Limited (PANACEABIO.BO)

INR 545.15

(-1.37%)

EBITDA Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual EBITDA in 2023 was -200.6 Million INR , up 59.62% from previous year.
Panacea Biotec Limited's latest quarterly EBITDA in 2024 Q1 was -139.9 Million INR , down -199.2% from previous quarter.
Panacea Biotec Limited reported an annual EBITDA of 563.65 Million INR in 2022, down -2876.81% from previous year.
Panacea Biotec Limited reported an annual EBITDA of 16.73 Billion INR in 2021, down -101.92% from previous year.
Panacea Biotec Limited reported a quarterly EBITDA of 55.3 Million INR for 2023 Q3, up 1775.76% from previous quarter.
Panacea Biotec Limited reported a quarterly EBITDA of -3.3 Million INR for 2023 Q2, up 92.2% from previous quarter.

Annual EBITDA Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual EBITDA of Panacea Biotec Limited (2023 - 2004)

Year	EBITDA	EBITDA Growth
2023	-200.6 Million INR	59.62%
2022	563.65 Million INR	-2876.81%
2021	16.73 Billion INR	-101.92%
2020	866.06 Million INR	-4.04%
2019	456.49 Million INR	200.94%
2018	2.07 Billion INR	-198.33%
2017	941.25 Million INR	-13.26%
2016	1.16 Billion INR	-18.86%
2015	1.81 Billion INR	97.32%
2014	723.6 Million INR	190.45%
2013	1.1 Billion INR	28.41%
2012	-676.5 Million INR	-30.63%
2011	-774.8 Million INR	-125.85%
2010	2.99 Billion INR	36.24%
2009	2.2 Billion INR	791.29%
2008	245.48 Million INR	-90.09%
2007	2.49 Billion INR	-6.53%
2006	2.67 Billion INR	102.42%
2005	1.31 Billion INR	90.5%
2004	692.52 Million INR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-139.9 Million INR	-199.2%
2023 Q3	55.3 Million INR	1775.76%
2023 Q2	-3.3 Million INR	92.2%
2023 Q1	-42.3 Million INR	-170.42%
2023 FY	- INR	59.62%
2023 Q4	-60.4 Million INR	-209.22%
2022 Q2	66.1 Million INR	109.78%
2022 FY	- INR	-2876.81%
2022 Q4	60.07 Million INR	-72.51%
2022 Q3	218.5 Million INR	230.56%
2022 Q1	-676 Million INR	-104.1%
2021 FY	- INR	-101.92%
2021 Q3	135.2 Million INR	67.95%
2021 Q2	80.5 Million INR	379.17%
2021 Q1	16.8 Million INR	-69.35%
2021 Q4	16.49 Billion INR	12097.17%
2020 Q4	54.82 Million INR	-67.73%
2020 FY	- INR	-4.04%
2020 Q1	237.9 Million INR	1.46%
2020 Q2	400.8 Million INR	68.47%
2020 Q3	169.9 Million INR	-57.61%
2019 Q4	234.48 Million INR	-41.58%
2019 Q2	-25.1 Million INR	-108.81%
2019 FY	- INR	200.94%
2019 Q3	401.4 Million INR	1699.2%
2019 Q1	284.8 Million INR	142.9%
2018 Q2	-81.4 Million INR	36.11%
2018 FY	- INR	-198.33%
2018 Q4	-663.8 Million INR	-359.6%
2018 Q3	255.7 Million INR	414.13%
2018 Q1	-127.4 Million INR	0.0%
2017 FY	- INR	-13.26%
2016 FY	- INR	-18.86%
2015 FY	- INR	97.32%
2014 FY	- INR	190.45%
2013 FY	- INR	28.41%
2012 FY	- INR	-30.63%
2011 FY	- INR	-125.85%
2010 FY	- INR	36.24%
2009 FY	- INR	791.29%
2008 FY	- INR	-90.09%
2007 FY	- INR	-6.53%
2006 FY	- INR	102.42%
2005 FY	- INR	90.5%
2004 FY	- INR	0.0%

Peer EBITDA Comparison of Panacea Biotec Limited

Name	EBITDA	EBITDA Difference
Alfavision Overseas (India) Limited	10.12 Million INR	2081.43%
Biocon Limited	41.52 Billion INR	100.483%
Blue Jet Healthcare Limited	2.29 Billion INR	108.751%
Concord Biotech Limited	4.65 Billion INR	104.306%
Dishman Carbogen Amcis Limited	3.07 Billion INR	106.53%
FERMENTA BIOTECH LIMITED	262.68 Million INR	176.366%
GENOMIC VALLEY BIOTECH LIMITED	147.4 Thousand INR	136190.419%
Lyka Labs Limited	167.58 Million INR	219.698%
SAMSRITA LABS LIMITED	-2.46 Million INR	-8052.98%
Servoteach Industries Limited	- INR	Infinity%
SMS Lifesciences India Limited	349.41 Million INR	157.411%
Supriya Lifescience Limited	1.83 Billion INR	110.927%
Syngene International Limited	10.84 Billion INR	101.849%
TAKE Solutions Limited	-1.05 Billion INR	80.911%
Titan Biotech Limited	360.29 Million INR	155.676%
Transgene Biotek Limited	-4.33 Million INR	-4523.185%
Vanta Bioscience Limited	14.19 Million INR	1513.572%